Connection

Giuseppe Curigliano to Cyclin-Dependent Kinase 4

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Cyclin-Dependent Kinase 4.
Giuseppe Curigliano
Connection Strength
1.272
Cyclin-Dependent Kinase 4
  1. Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting. Curr Opin Oncol. 2017 Nov; 29(6):428-433.
    View in: PubMed
    Score: 0.720
  2. Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors. Cancer Treat Rev. 2019 Mar; 74:21-28.
    View in: PubMed
    Score: 0.196
  3. Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opin Pharmacother. 2018 Feb; 19(3):299-305.
    View in: PubMed
    Score: 0.183
  4. Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer. Expert Opin Drug Metab Toxicol. 2017 May; 13(5):575-581.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.